Targeting human satellite II (HSATII)
US12152241B2 · kind B2 · utility
0Cited by
168References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 2019 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | Apr 24, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating cancer, e.g., cancer of epithelial origin, by specifically targeting human satellite II (HSATII) using sequence specific agents such as oligonucleotides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.